Literature DB >> 21698652

Sodium and chloride channelopathies with myositis: coincidence or connection?

Emma Matthews1, James A L Miller, Malcolm R MacLeod, James Ironside, Gareth Ambler, Robin Labrum, Richa Sud, Janice L Holton, Michael G Hanna.   

Abstract

INTRODUCTION: A proximal myopathy develops in some patients with muscle channelopathies, but the causative molecular mechanisms are unknown.
METHODS: We reviewed retrospectively all clinical and muscle biopsy findings of 3 patients with channelopathy and additional myositis. Direct DNA sequencing was performed.
RESULTS: Pathogenic mutations were identified in each case. Biopsies demonstrated inflammatory infiltrates.
CONCLUSIONS: Clinicians should consider muscle biopsy in channelopathy patients with severe myalgia and/or subacute weakness and accompanying elevated creatine kinase. Chance association of myositis and channelopathy is statistically unlikely. An alternative hypothesis suggests that inflammatory insults could contribute to myopathy in some patients.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698652      PMCID: PMC3136616          DOI: 10.1002/mus.22120

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  22 in total

1.  New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis.

Authors:  S Vicart; D Sternberg; E Fournier; F Ochsner; P Laforet; T Kuntzer; B Eymard; B Hainque; B Fontaine
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

2.  Autosomal dominant monosymptomatic myotonia permanens.

Authors:  Eskild Colding-Jørgensen; Morten Duno; John Vissing
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

3.  Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita.

Authors:  A L George; K Sloan-Brown; G M Fenichel; G A Mitchell; R Spiegel; R M Pascuzzi
Journal:  Hum Mol Genet       Date:  1994-11       Impact factor: 6.150

4.  A novel muscle sodium channel mutation causes painful congenital myotonia.

Authors:  J Rosenfeld; K Sloan-Brown; A L George
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

Review 5.  Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis.

Authors:  James G Tidball; Michelle Wehling-Henricks
Journal:  Curr Opin Rheumatol       Date:  2005-11       Impact factor: 5.006

6.  Electromyography guides toward subgroups of mutations in muscle channelopathies.

Authors:  Emmanuel Fournier; Marianne Arzel; Damien Sternberg; Savine Vicart; Pascal Laforet; Bruno Eymard; Jean-Claude Willer; Nacira Tabti; Bertrand Fontaine
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

7.  Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis.

Authors:  L J Ptáĉek; R Tawil; R C Griggs; G Meola; P McManis; R J Barohn; J R Mendell; C Harris; R Spitzer; F Santiago
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

8.  Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions.

Authors:  D Fialho; S Schorge; U Pucovska; N P Davies; R Labrum; A Haworth; E Stanley; R Sud; W Wakeling; M B Davis; D M Kullmann; M G Hanna
Journal:  Brain       Date:  2007-10-11       Impact factor: 13.501

9.  Correlating phenotype and genotype in the periodic paralyses.

Authors:  T M Miller; M R Dias da Silva; H A Miller; H Kwiecinski; J R Mendell; R Tawil; P McManis; R C Griggs; C Angelini; S Servidei; J Petajan; M C Dalakas; L P W Ranum; Y H Fu; L J Ptácek
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

10.  What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed.

Authors:  E Matthews; S V Tan; D Fialho; M G Sweeney; R Sud; A Haworth; E Stanley; G Cea; M B Davis; M G Hanna
Journal:  Neurology       Date:  2008-01-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.